| Hazard Information | Back Directory | [Description]
Sipuleucel-T is the first FDA-approved therapeutic cancer vaccine. It
is approved for the treatment of asymptomatic or minimally symptomatic
metastatic castration-resistant (hormone-refractory) prostate cancer.
Sipuleucel-T is described as a therapy rather than a precisely defined
therapeutic agent because it is an autologous vaccine that is generated
from each individual patient's own blood cells. | [Originator]
Dendreon (United States) | [Brand name]
Provenge |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
m.is0513.com/ShowSupplierProductsList15748/0.htm |
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|